Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Entasis Therapeutics Holdings Inc | ETTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.045 | -0.8% | 5.55 | 5.83 | 5.55 | 5.55 | 5.595 | 18:00:37 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 0.01 | 13.65 | 13.64 | 99.93% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 124 | 6,008 | $ 5.62 | $ 33,767 | 9,625 | 3.9703 - 9.25 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:59:41 | 113 | $ 5.55 | USD |
Entasis Therapeutics Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 72.90M | 13.13M | $ -32.95M | 78.69 | 0.10 | 13.11M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | 8.00 | 0.20% |
Entasis Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ETTX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 5.84 | 5.98 | 5.55 | 5.72 | 4,645 | -0.29 | -4.97% |
| 1 Month | 5.80 | 6.28 | 5.55 | 5.82 | 5,123 | -0.25 | -4.31% |
| 3 Months | 9.06 | 9.25 | 5.03 | 6.37 | 15,998 | -3.51 | -38.74% |
| 6 Months | 6.0201 | 9.25 | 5.03 | 6.47 | 12,651 | -0.4701 | -7.81% |
| 1 Year | 6.44 | 9.25 | 3.9703 | 6.04 | 16,534 | -0.89 | -13.82% |
| 3 Years | 13.45 | 13.70 | 3.9703 | 7.87 | 33,466 | -7.90 | -58.74% |
| 5 Years | 13.45 | 13.70 | 3.9703 | 7.87 | 33,466 | -7.90 | -58.74% |
Entasis Therapeutics Description
| Entasis Therapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company is engaged in the discovery, development, and commercialization of novel antibacterial products to treat serious infections caused by multi-drug resistant Gram-negative bacteria. It has the discovery, development, and commercialization of novel antibacterial products to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Its products candidate includes etx2514sul, zoliflodacin, etx0282cpdp, and nbp program. |
